Drug-induced thrombocytopenia and thrombosis: Evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial Benjamin M. SciricaChristopher P. CannonEugene Braunwald Featured Investigation Pages: 95 - 102
The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events Burak PamukcuHuseyin OflazYilmaz Nisanci Clinical Trials and Thromboepidemiology Pages: 103 - 110
Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients with and without thrombosis Aydan ErogluArzu UluNejat Akar Clinical Trials and Thromboepidemiology Pages: 111 - 112
Oral anticoagulant treatment: Risk factors involved in 500 intracranial hemorrhages A. CantalapiedraO. GutierrezL. J. García-Frade Clinical Trials and Thromboepidemiology Pages: 113 - 120
Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-ßeta-0 thalassemia patients Hussain Isma’eelM. S. ArnaoutAli Taher Clinical Trials and Thromboepidemiology Pages: 121 - 123
Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood Christopher J. BoosDeirdre A. LaneGregory Y. H. Lip Basic and Translational Science Pages: 125 - 131
Low levels of activated factor VII in systemic sclerosis Alessandro VolpeGian Luca SalvagnoGian Cesare Guidi Basic and Translational Science Pages: 133 - 138
Possible mechanisms of drug-induced aspirin and clopidogrel resistance Walter S. SchroederLinda GhobrialPritesh J. Gandhi Frontiers in Thrombocardiology Pages: 139 - 150
Eptifibatide-induced thrombocytopenia and thrombosis Slava EpelmanDeepu NairArman T. Askari Case Reports and Reviews Pages: 151 - 154
Proteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes Patrick K. Y. GoonGregory Y. H. Lip Letter to the Editor Pages: 155 - 156